Jayastu Senapati

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 36

Top Topics

Newly Diagnosed

Tyrosine Kinase

Stem Cell Transplantation

Top Venues

American journal of hematology

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Fady Gh Haddad, Koiji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace S Hwang, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A Abbas, Nicholas James Short, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO oncology practice (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Nicholas James Short, Elias J Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M Kantarjian
A Phase 1/2 Study of Mini-Hyper-CVD plus Venetoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood advances (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Koji Sasaki, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Adam S Kittai, David A Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carrie Ho, Caron A Jacobson, Samantha Jaglowski, Nitin Jain, Kevin H Lin, Cecelia Miller, Christine McCarthy, Zulfa Omer, Erin M Parry, Manoj Ponadka Rai, Kerry A Rogers, Aditi Saha, Levanto Schachter, Hamish Scott, Jayastu Senapati, Mazyar Shadman, Tanya Siddiqi, Deborah M Stephens, Vinay Vanguru, William G Wierda, Jennifer A Woyach, Philip A Thompson
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer 130 (19) (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Elias J Jabbour, Fadi G Haddad, Nicholas James Short, Jayastu Senapati, Nitin Jain, Koiji Sasaki, Jeffrey L Jorgensen, Sa A Wang, Yesid Alvarado, Xuemei Wang, Courtney D D DiNardo, Lucia Masarova, Tapan M Kadia, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Inotuzumab Ozogamicin for Measurable Residual Disease in Acute Lymphoblastic Leukemia in Remission. Blood (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias Jabbour, Tareq Abuasab, Nicholas Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas James Short, Ghayas C Issa, Abhishek Maiti, Hussein A Abbas, Naval G Daver, Naveen Pemmaraju, Sherry A Pierce, Kelly Sharon Chien, Koiji Sasaki, Tapan M Kadia, Danielle Hammond, Gautam Borthakur, Keyur Pravinchandra Patel, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia-Manero, Courtney D D DiNardo
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias J Jabbour, Tareq Abuasab, Nicholas James Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles G Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Jayastu Senapati, Elias J Jabbour, Marina Y Konopleva, Nicholas James Short, Guillin Tang, Naval G Daver, Partow Kebriaei, Tapan Mahendra Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtney D D DiNardo, Koiji Sasaki, Gautam Borthakur, Beenu Thakral, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Farhad Ravandi, Kathryn G Roberts, Charles G Mullighan, Hagop M Kantarjian, Nitin Jain
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO precision oncology 7 (2023)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Jayastu Senapati, Mahran Shoukier, Guillermo Garcia Manero, Xuemei Wang, Keyur Patel, Tapan Mahendra Kadia, Farhad Ravandi, Naveen Pemmaraju, Maro Ohanian DO, Naval G Daver, Courtney D D DiNardo, Yesid Alvarado, Jeffrey Aldrich, Gautam Borthakur
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia. American journal of hematology 97 (5) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology (2022)
Naveen Pemmaraju, Hagop M Kantarjian, Kendra L Sweet, Eunice S Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Y Konopleva, Arthur E Frankel, Vikas K Gupta, Ruben A Mesa, Matthew L Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James R Mason, Maria Teresa García-Romero, Norma C Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland Bruno Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K Rampal, Marcos de Lima, James M Foran, Amir T Fathi, Aric C Hall, Meagan A Jacoby, Jeffrey E Lancet, Gabriel N Mannis, Anthony S Stein, Alice S Mims, David A Rizzieri, Rebecca L Olin, Alexander E Perl, Gary J Schiller, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew J Wieduwilt, Naval G Daver, Farhad Ravandi, Sumithira Vasu, Monica L Guzman, Gail J Roboz, Joseph D Khoury, Muzaffar H Qazilbash, Leomar Y Ballester, Branko Cuglievan, Yazan F Madanat, Mohamed A Kharfan-Dabaja, Anna B Pawlowska, Justin Taylor, Martin S Tallman, Prajwal Dhakal, Andrew A Lane
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood (2022)
Jayastu Senapati, Srdan Verstovsek, Lucia Masarova, Naveen Pemmaraju, Keyur P Patel, Guillermo Montalban-Bravo, Sherry A Pierce, Lingsha Zhou, Guillermo Garcia-Manero, Hagop M Kantarjian, Prithviraj Bose
Impact of SF3B1 mutation in myelofibrosis. Leukemia & lymphoma 63 (11) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Nitin Jain, Jayastu Senapati, Beenu Thakral, Alessandra Ferrajoli, Phillip A Thompson, Jan A Burger, Sreyashi Basu, Tapan M Kadia, Naval G Daver, Gautam Borthakur, Marina Konopleva, Naveen Pemmaraju, Erin M Parry, Catherine J Wu, Joseph D Khoury, Carlos E Bueso-Ramos, Naveen Garg, Xuemei Wang, Wanda Lopez, Ana Ayala, Susan M O'Brien, Hagop M Kantarjian, Michael J Keating, James P Allison, Padmanee Sharma, William G Wierda
A Phase 2 Study of Nivolumab Combined with Ibrutinib in Patients with Diffuse Large B-cell Richter Transformation of CLL. Blood advances (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Prajwal C Boddu, Jayastu Senapati, Farhad Ravandi-Kashani, Elias J Jabbour, Nitin Jain, Mary Ayres, Yuling Chen, Michael J Keating, Hagop M Kantarjian, Varsha Gandhi, Tapan Mahendra Kadia
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies. Cancer (2022)
Jayastu Senapati, Rishi Dhawan, Mukul Aggarwal, Pradeep Kumar, Ganesh Kumar Vishwanathan, Jasmita Dass, Seema Tyagi, Manoranjan Mahapatra, Tulika Seth
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country. Leukemia & lymphoma 62 (6) (2021)